{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T23:13:59Z","timestamp":1789686839123,"version":"4.0.1"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T00:00:00Z","timestamp":1740268800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.semarthrit.2025.152666","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T11:49:21Z","timestamp":1740397761000},"page":"152666","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"S","title":["Immunotherapy in cancer"],"prefix":"10.1016","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6565-3393","authenticated-orcid":false,"given":"Robert","family":"Zeiser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2025.152666_bib0001","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nm.4484","article-title":"Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD mutant leukemia cells","volume":"24","author":"Mathew","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.semarthrit.2025.152666_bib0002","doi-asserted-by":"crossref","DOI":"10.1172\/JCI177460","article-title":"Oncogene induced TIM-3 ligand expression dictates susceptibility to anti-TIM-3 therapy in mice","author":"Talvard-Balland","year":"2024","journal-title":"J Clin Invest"},{"issue":"429","key":"10.1016\/j.semarthrit.2025.152666_bib0003","doi-asserted-by":"crossref","first-page":"eaam7729","DOI":"10.1126\/scitranslmed.aam7729","article-title":"Oncogenic JAK2V617F causes PD-L1 expression mediating immune-escape in myeloproliferative neoplasms","volume":"10","author":"Prestipino","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.semarthrit.2025.152666_bib0004","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-23-3553","article-title":"Oncogenic calreticulin induces immune escape by stimulating TGF-beta expression and regulatory T cell expansion in the bone marrow microenvironment","author":"Schmidt","year":"2024","journal-title":"Cancer Res"},{"issue":"567","key":"10.1016\/j.semarthrit.2025.152666_bib0005","doi-asserted-by":"crossref","first-page":"eabb8969","DOI":"10.1126\/scitranslmed.abb8969","article-title":"Metabolic reprogramming of donor T cells enhances graft-versus-leukemia effects in mice and humans","volume":"12","author":"Uhl","year":"2020","journal-title":"Sci Transl Med"},{"issue":"751","key":"10.1016\/j.semarthrit.2025.152666_bib0006","doi-asserted-by":"crossref","first-page":"eadj9672","DOI":"10.1126\/scitranslmed.adj9672","article-title":"Anti-PD-1 cancer immunotherapy induces central nervous system immune-related adverse events by microglia activation","volume":"16","author":"Vinnakota","year":"2024","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.semarthrit.2025.152666_bib0007","doi-asserted-by":"crossref","DOI":"10.1038\/s43018-024-00764-7","article-title":"Targeting TGFbeta-activated kinase-1 activation in microglia reduces CAR T immune effector cell-associated neurotoxicity syndrome","author":"Vinnakota","year":"2024","journal-title":"Nat Cancer"},{"key":"10.1016\/j.semarthrit.2025.152666_bib0008","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1182\/blood.2020005957","article-title":"Glucagon-like peptide 2 for intestinal stem cell and Paneth cell repair during graft-versus-host disease in mice and humans","volume":"136","author":"Norona","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.semarthrit.2025.152666_bib0009","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1056\/NEJMoa2033122","article-title":"Ruxolitinib for glucocorticoid-refractory chronic graft-versus-host disease","volume":"385","author":"Zeiser","year":"2021","journal-title":"N Eng J Med"},{"key":"10.1016\/j.semarthrit.2025.152666_bib0010","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1056\/NEJMoa1917635","article-title":"Ruxolitinib for glucocorticoid-refractory acute graft-versus-host disease","volume":"382","author":"Zeiser","year":"2020","journal-title":"N Eng J Med"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004901722500037X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004901722500037X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T15:44:40Z","timestamp":1744731880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004901722500037X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":10,"alternative-id":["S004901722500037X"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2025.152666","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunotherapy in cancer","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2025.152666","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152666"}}